| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCHEARTFAILURE.110.959882 |
| P698 | PubMed publication ID | 21562056 |
| P50 | author | Ajay M. Shah | Q37839047 |
| Chris P. Gale | Q43095044 | ||
| Stephen Wheatcroft | Q43402450 | ||
| Mark Kearney | Q43402570 | ||
| Klaus K. Witte | Q50842463 | ||
| Richard Cubbon | Q53769733 | ||
| Matthew Benjamin Kahn | Q58453923 | ||
| Keith Fox | Q72227369 | ||
| Azfar Zaman | Q89863563 | ||
| Robert J Sapsford | Q114293858 | ||
| Phillip D Batin | Q114518391 | ||
| Lorraine C Kearney | Q115121202 | ||
| W Paul Brooksby | Q117250515 | ||
| Pauline E Barlow | Q117250516 | ||
| P2093 | author name string | Clyde B Schechter | |
| David Groves | |||
| Anthony C Fisher | |||
| Adil Rajwani | |||
| Wazir Baig | |||
| Jim Nolan | |||
| Steven J Lindsay | |||
| Jon A Byrne | |||
| P433 | issue | 4 | |
| P921 | main subject | heart failure | Q181754 |
| systole | Q496359 | ||
| chronic heart failure | Q11829287 | ||
| P304 | page(s) | 396-403 | |
| P577 | publication date | 2011-05-11 | |
| P1433 | published in | Circulation: Heart Failure | Q2865806 |
| P1476 | title | Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras | |
| P478 | volume | 4 |
| Q36577192 | Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure |
| Q92899265 | Anaerobic Bacteremias in Left Ventricular Assist Devices and Advanced Heart Failure |
| Q38748870 | Automated identification and predictive tools to help identify high-risk heart failure patients: pilot evaluation |
| Q52840100 | Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure. |
| Q47701044 | Can Mindfulness Training Improve Medication Adherence? Integrative Review of the Current Evidence and Proposed Conceptual Model |
| Q52836737 | Chronic heart failure and type 2 diabetes mellitus: The last battle? |
| Q95938141 | Clinical Course after a First Episode of Heart Failure: Insights from the Framingham Heart Study |
| Q94582978 | Contemporary use of devices in chronic heart failure in the Netherlands |
| Q37486284 | Decision making in advanced heart failure: a scientific statement from the American Heart Association |
| Q48516435 | Devices in heart failure; diagnosis, detection and disease modification. |
| Q42322227 | Diabetes mellitus and heart failure: a deadly duo. |
| Q44916704 | Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology |
| Q51281986 | Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction. |
| Q42740422 | Diff'rent strokes, different folks: advanced heart failure's changing outlook |
| Q89375106 | Differential Response to Heart Failure Medications in Children |
| Q33969031 | Dysregulation of cardiolipin biosynthesis in pediatric heart failure |
| Q99409958 | Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fraction |
| Q41710632 | Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients |
| Q36968934 | Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study |
| Q48073496 | Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial |
| Q92333056 | Family caregiving for persons with advanced heart failure: An integrative review |
| Q37538031 | Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association |
| Q43129510 | Heart failure: Heart failure clinical trials: how do we define success? |
| Q37573616 | Home monitoring of heart failure patients at risk for hospital readmission using a novel under-the-mattress piezoelectric sensor: A preliminary single centre experience |
| Q94604416 | Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction |
| Q38560197 | Most Heart Failure Patients Die from Pump Failure: Implications for Therapy |
| Q60918375 | Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age |
| Q47096424 | Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss. |
| Q58121829 | Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction |
| Q33659469 | Prospective development and validation of a model to predict heart failure hospitalisation |
| Q61307046 | Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care |
| Q36410248 | Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis |
| Q47550819 | Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure |
| Q38415190 | Sudden cardiac death in patients with diabetes mellitus and chronic heart failure |
| Q55249978 | Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia. |
| Q36908694 | Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center |
| Q36378477 | Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function |
| Q50714692 | Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012. |
| Q61842050 | Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure |
| Q50016512 | Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity |
| Q41612970 | miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway |
| Q37235097 | β-Adrenergic receptor antagonism in mice: a model for pediatric heart disease. |
Search more.